In line with our previous results in esophageal cancer cells, the treatment of prostate cancer cells with STL001 in combination with taxol enhanced the cytotoxic effects of taxol therapy, detected by induction of strong apoptotic cell death indicated by caspase-3 cleavage (Fig. 6C). This evidence concerns the gene CASP3 and prostate carcinoma.